• Swiss medical weekly · Dec 1998

    Case Reports

    [Chronic meningococcemia--a rare, but characteristic disease picture].

    • H Grob, R Frei, A Tyndall, and P H Itin.
    • Dermatologische Universitätsklinik Basel.
    • Swiss Med Wkly. 1998 Dec 12;128(50):1988-93.

    AbstractChronic meningococcaemia is a rare clinical manifestation of invasive infection by Neisseria meningitidis. The clinical signs and symptoms are recurrent fever, skin rash, arthralgias and headache. This constellation is rather typical and may enable the clinician to establish the diagnosis. The clinical diagnosis is confirmed by the growth of Neisseria meningitidis in the blood culture. In addition, the clinical course under antibiotic treatment leads to a dramatic improvement within 24-48 hours. Positive cultures may be obtained by needle aspiration or skin biopsy. There are a few reports on patients with deficiency of late complement components or immunoglobulin deficiency. We report on two patients with the typical findings of chronic meningococcaemia.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.